Profile
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera’s versatile platform shows promise in broader immunomodulation applications. This potential has already attracted a major pharmaceutical partnership focused on enhancing mRNA vaccine efficacy for infectious diseases, while Esphera independently explores additional immunoregulatory therapies.
Website
Contact
-
John Bell, President and Co-FounderTel: +1 613-286-2396Email: jbell@ohri.ca
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors… -
Custom Biologics is a regulatory compliant, large molecule bioanalytical… -
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative…
-
Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product,… -
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative… -
HDAX Therapeutics is a biotechnology company pioneering a novel approach to targeting… -
ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics… -
Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with… -
Iseehear Inc. is a leading provider of comprehensive IT solutions for the biomedical research… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is… -
Mediphage, a Toronto-based biotechnology company, has developed a proprietary and scalable manufacturing process… -
Plasmid DNA is starting material for cell and gene, RNA and DNA therapies… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring… -
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
PurMinds NeuroPharma is a neuro-medicine development company pursuing breakthrough solutions for the treatment of… -
QurCan Therapeutics is developing tissue and cell-targeted genetic medicine using its proprietary hybrid polymer-… -
Spiderwort is a tissue engineering company that develops cellulose-based scaffolds for use in regenerative… -
TheraVac Biologics is developing novel vaccines and immunotherapies for aging-related diseases associated with…